SECURITIES AND EXHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
(Rule 13d-102)
UNDER THE SECURITIES ECHANGE ACT OF 1934
(Amendment No. 2 )*
------------------------------------
Palomar Medical Technologies, Inc.
---------------------------------------------------------
(Name of Issuer)
Common Stock
---------------------------------------------------------
(Title of Class of Securities)
697529 10 5
---------------------------------------------------------
(CUSIP Number)
Check the following box is a fee is being paid with this statement [ ]. (A fee
is not required only of the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4 Pages
<PAGE>
CUSIP No. 597529 10 5 13G Page 2 of 4 Pages
- -------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVER PERSON
Michael Smotrich, SS# ###-##-####
- -------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3. SEC USE ONLY
- -------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen
- -------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 1,216,256
BENEFICIALLY ____________________________________________________
OWNED BY 6. SHARED VOTING POWER
EACH 8,000
REPORTING ____________________________________________________
PERSON 7. SOLE DISPOSITIVE POWER
WITH 1,216,256
----------------------------------------------------
8. SHARED DISPOSITIVE POWER
8,000
- -------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,224,256
- -------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
- -------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.0%
- -------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILING OUT!
Page 2 of 4 Pages
<PAGE>
Item 1. (a) Name of Issuer: Palomar Medical Technologies, Inc.
(b) Address of Issuer's Principal Executive Offices:
66 Cherry Hill Drive, Beverly, MA 01915
Item 2. (a) Name of Person Filing: Michael Smotrich
(b) Address of Principal Business Office: 66 Cherry Hill Drive
Beverly, MA 01915
(c) Citizenship: U.S. Citizen
(d) Title of Class of Securities: Common Stock,
$.01 par value per share
(e) CUSIP Number: 597529 10 5
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b),
check whether the person is a:
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(b) [ ] Bank as defined in section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in section 3(a)(19) of the Act
(d) [ ] Investment Company registered under section 8 of the
Investment Company Act
(e) [ ] Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see Section240.13d(b)(1)(ii)(F)
(g) [ ] Parent Holding Company, in accordance with Section
240.13d-1(b)(1)(ii)(G) (h) [ ] Group, in accordance with
Section 240.13d-1(b)(1)(ii)(H)
Item 4. Ownership.
(a) Amount Beneficially Owned: 1,224,256
(b) Percent of Class: 4.0%
(c) Number of Shares as to which person has:
(i) Sole power to vote or to direct the vote: 1,216,256
(ii) Shared power to vote or to direct the vote: 8,000
(iii) Sole power to dispose or to direct the disposition of: 1,216,256
(iv) Shared power to dispose or to direct the disposition of: 8,000
Item 5. Ownership of Five Percent or Less of a Class.
On March 13, 1996, Michael Smotrich's Percentage of Ownership decreased
to 4.9% due to the issuance of Common Stock. Although there were
additional options and warrants granted from March 13, 1996 through
December 31, 1996, the total percentage to date is 4.0%.
Item 6. Ownership of More than Five Percent on Behalf of Another Person. N/A
Item 7. Identification and Classification of the Subsidiary which Acquired the
Security Being Reported on By the Parent Holding Company. N/A
Item 8. Identification and Classification of Members of the Group. N/A
Page 3 of 4 Pages
<PAGE>
Item 9. Notice of Dissolution of Group. N/A
Item 10. Certification. N/A
By signing below I/We certify that, to the best of my knowledge and
belief, the securities referred to above where acquired in the ordinary
course of business and were not acquired for the purpose of and do not
have the effect of changing or influencing the control of the issuer of
such securities and were not acquired in connection with or as a
participant in any transaction having such purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
February 26, 1997
---------------------------
(Date)
/s/ Michael Smotrich
---------------------------
(Signature)
Michael Smotrich, President
---------------------------
(Name/Title
Page 4 of 4 Pages
